Clinical trial Recruiting at 1 site Observational Ages 18 and up

Minimally invasive hemorrhoidectomy for grade III/IV hemorrhoids

Official title: Prospective Observational Study to Assess the Reproducibility of Minimally Invasive Surgery in Closed Excisional Hemorrhoidectomy: Phase 2A of theI DEAL Framework

Run by Hospital Son Llatzer · NCT07534761 · Data updated 2026-11-12

This study tests a minimally invasive hemorrhoidectomy technique in adults with grade III or IV hemorrhoids to see if it provides relief with less pain than traditional methods.

More Hemorrhoidectomy trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorHospital Son Llatzer
Academic / other
Locations1 site (Palma, Balearic Islands)
StatusRecruiting
StartedJune 1, 2026
Main results expectedDecember 1, 2026
Study endsDecember 1, 2027
Registry record updatedSeptember 22, 2026
Trial IDNCT07534761 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with Goligher grade III or IV hemorrhoids who require surgical hemorrhoidectomy and consent to participate.

Probably not a fit

Patients with acute hemorrhoidal thrombosis, prior hemorrhoid surgery, coexisting anorectal conditions, inflammatory bowel disease, active cancer, or language barriers may not experience benefit from this specific approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates a minimally invasive approach to hemorrhoidectomy for patients with Goligher grade III–IV hemorrhoids who require surgery. The procedure uses enhanced visualization and precision to reduce tissue injury compared with standard excisional methods. It aims to document safety, feasibility, and postoperative pain, healing, and recovery within the IDEAL framework for surgical innovation. Participants are adults undergoing surgery at Hospital Son Llatzer in Palma, with careful inclusion and exclusion criteria to select appropriate candidates. Data will describe outcomes and inform future refinement and broader evaluation of the technique.

Why it matters

Potential benefit: If successful, patients may experience less postoperative pain and improved healing after hemorrhoidectomy with the minimally invasive approach.

How similar studies have gone: Previous work shows MIS benefits in other surgical fields, but its use in anal surgery is novel and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age over 18 years
* Grade III/IV hemorrhoids
* Indication for CEH surgery
* Signed written informed consent

Exclusion Criteria:

* Acute hemorrhoidal disease (thrombosis)
* Previous hemorrhoid surgery
* Coexistence of anal fissure
* Coexistence of perianal fistula
* Coexistence of rectal or anal prolapse
* Active inflammatory bowel disease
* Active anal or colorectal cancer
* Language barrier or difficulty in oral and/or written comprehension

Where it's running

  • Hospital Son Llatzer
    Palma, Balearic Islands, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.